Literature DB >> 15780178

Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.

Shin Ling Hwang1, Nancy Pei-Yee Chung, Jacqueline Kwai-Yi Chan, Chen-Lung Steve Lin.   

Abstract

Indoleamine 2, 3-dioxygenase (IDO) is a rate-limiting enzyme for the tryptophan catabolism. In human and murine cells, IDO inhibits antigen-specific T cell proliferation in vitro and suppresses T cell responses to fetal alloantigens during murine pregnancy. In mice, IDO expression is an inducible feature of specific subsets of dendritic cells (DCs), and is important for T cell regulatory properties. However, the effect of IDO and tryptophan deprivation on DC functions remains unknown. We report here that when tryptophan utilization was prevented by a pharmacological inhibitor of IDO, 1-methyl tryptophan (1MT), DC activation induced by pathogenic stimulus lipopolysaccharide (LPS) or inflammatory cytokine TNF-alpha was inhibited both phenotypically and functionally. Such an effect was less remarkable when DC was stimulated by a physiological stimulus, CD40 ligand. Tryptophan deprivation during DC activation also regulated the expression of CCR5 and CXCR4, as well as DC responsiveness to chemokines. These results suggest that tryptophan usage in the microenvironment is essential for DC maturation, and may also play a role in the regulation of DC migratory behaviors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780178     DOI: 10.1038/sj.cr.7290282

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  32 in total

1.  Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis.

Authors:  Patricia A Zunszain; Christoph Anacker; Annamaria Cattaneo; Shanas Choudhury; Ksenia Musaelyan; Aye Mu Myint; Sandrine Thuret; Jack Price; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2011-11-09       Impact factor: 7.853

2.  Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Authors:  Esther Larrea; José I Riezu-Boj; Lucía Gil-Guerrero; Noelia Casares; Rafael Aldabe; Pablo Sarobe; María P Civeira; Jonathan L Heeney; Christine Rollier; Babs Verstrepen; Takaji Wakita; Francisco Borrás-Cuesta; Juan J Lasarte; Jesús Prieto
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques.

Authors:  Anna Hryniewicz; Adriano Boasso; Yvette Edghill-Smith; Monica Vaccari; Dietmar Fuchs; David Venzon; Janos Nacsa; Michael R Betts; Wen-Po Tsai; Jean-Michel Heraud; Brigitte Beer; Diann Blanset; Claire Chougnet; Israel Lowy; Gene M Shearer; Genoveffa Franchini
Journal:  Blood       Date:  2006-08-08       Impact factor: 22.113

4.  1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.

Authors:  Sophie Agaugué; Laure Perrin-Cocon; Frédéric Coutant; Patrice André; Vincent Lotteau
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

5.  Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts.

Authors:  Mi-Kyung Park; Hye-Jwa Oh; Yang-Mi Heo; Eun-Mi Park; Mi-La Cho; Ho-Youn Kim; Sung-Hwan Park
Journal:  Exp Mol Med       Date:  2011-08-31       Impact factor: 8.718

6.  Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.

Authors:  Anle Zhang; Yuanhong Zheng; Zujun Que; Lingling Zhang; Shengchao Lin; Vanminh Le; Jianwen Liu; Jianhui Tian
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-01       Impact factor: 4.553

7.  ANALYSIS OF DENDRITIC CELL STIMULATION UTILIZING A MULTI-FACETED NANOPOLYMER DELIVERY SYSTEM AND THE IMMUNE MODULATOR 1-METHYL TRYPTOPHAN.

Authors:  Kevin P Nikitczuk; Edmund C Lattime; Rene S Schloss; Martin L Yarmush
Journal:  Nano Life       Date:  2010-09-01

Review 8.  IDO-expressing regulatory dendritic cells in cancer and chronic infection.

Authors:  Alexey Popov; Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

Review 9.  IDO: a double-edged sword for T(H)1/T(H)2 regulation.

Authors:  Hui Xu; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Immunol Lett       Date:  2008-09-29       Impact factor: 3.685

10.  The subsets of dendritic cells and memory T cells correspond to indoleamine 2,3-dioxygenase in stomach tumor microenvironment.

Authors:  Fangxuan Li; Jinchao Huang; Shixia Li; Hui Li; Jinpu Yu; Xiubao Ren; Juntian Liu
Journal:  Tumour Biol       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.